Trial intelligence / Profile preview

DHEA in Respiratory Pulmonary Hypertension in Adults with COPD

NCT00581087Phase 3Completed

Sponsor
Centre Hospitalier Universitaire de Bordeaux
Start
Jan 2007
Primary completion
Jun 2015
Modality
Allosteric Modulators
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in pulmonary hypertension (PH) comparing DHEA with Placebo (2 arms). Primary endpoint: Six-Minute Walk Test at 1 year. Started Jan 2007; status: completed.

02

Drugs

dehydroepiandrosterone
03

Conditions

pulmonary hypertension (PH)

Beyond the preview

Go deeper on NCT00581087.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00581087.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call